Author:
Sun Jing-jing,Chen Yi-chao,Huang Yi-xian,Zhao Wen-chen,Liu Yan-hua,Venkataramanan Raman,Lu Bin-feng,Li Song
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference43 articles.
1. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G . Immunological aspects of cancer chemotherapy. Nat Rev Immunol 2008; 8: 59–73.
2. Sharon E, Streicher H, Goncalves P, Chen HX . Immune checkpoint inhibitors in clinical trials. Chin J Cancer 2014; 33: 434–44.
3. Pardoll DM . The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252–64.
4. Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, et al. Regulation of CTLA-4 expression during T cell activation. J Immunol 1996; 156: 4154–9.
5. Contardi E, Palmisano GL, Tazzari PL, Martelli AM, Fala F, Fabbi M, et al. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer 2005; 117: 538–50.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献